New drug combo targets tough breast cancer in Real-World study
Disease control
Not yet recruiting
This study looks at how well a drug called inavolisib works in real-world settings for people with a certain type of advanced breast cancer (HR-positive, HER2-negative, with a PIK3CA mutation). About 100 participants will take inavolisib along with hormone therapy, sometimes with…
Sponsor: xuliang • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC